These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 15975967)

  • 21. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
    Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
    Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A reappraisal of HAQ disability in rheumatoid arthritis.
    Wolfe F
    Arthritis Rheum; 2000 Dec; 43(12):2751-61. PubMed ID: 11145033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
    Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
    J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
    Strand V; Scott DL; Emery P; Kalden JR; Smolen JS; Cannon GW; Tugwell P; Crawford B;
    J Rheumatol; 2005 Apr; 32(4):590-601. PubMed ID: 15801012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generalization and extrapolation of treatment effects from clinical studies in rheumatoid arthritis.
    Nair SC; Kievit W; Janse RW; Bijlsma JW; Fransen J; Lafeber FP; Welsing PM
    Arthritis Care Res (Hoboken); 2014 Jul; 66(7):998-1007. PubMed ID: 24375965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction.
    Aletaha D; Funovits J; Smolen JS
    Ann Rheum Dis; 2011 May; 70(5):733-9. PubMed ID: 21321002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis.
    Cohen JD; Dougados M; Goupille P; Cantagrel A; Meyer O; Sibilia J; Daurès JP; Combe B
    J Rheumatol; 2006 Oct; 33(10):1936-41. PubMed ID: 16924692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.
    Pope JE; Khanna D; Norrie D; Ouimet JM
    J Rheumatol; 2009 Feb; 36(2):254-9. PubMed ID: 19132791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis.
    Revicki D; Ganguli A; Kimel M; Roy S; Chen N; Safikhani S; Cifaldi M
    Value Health; 2015 Dec; 18(8):1008-15. PubMed ID: 26686785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early local swelling and tenderness are associated with large-joint damage after 8 years of treatment to target in patients with recent-onset rheumatoid arthritis.
    van den Broek M; Dirven L; Kroon HM; Kloppenburg M; Ronday HK; Peeters AJ; Kerstens PJ; Huizinga TW; Lems WF; Allaart CF
    J Rheumatol; 2013 May; 40(5):624-9. PubMed ID: 23547212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritis.
    Blom M; Kievit W; Donders AR; den Broeder AA; Straten VH; Kuper I; Visser H; Jansen TL; Brus HL; Branten AJ; van de Laar MA; van Riel PL
    J Rheumatol; 2011 Nov; 38(11):2355-61. PubMed ID: 21885487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hand function tests are important and sensitive tools for assessment of treatment response in patients with rheumatoid arthritis.
    Eberhardt K; Sandqvist G; Geborek P
    Scand J Rheumatol; 2008; 37(2):109-12. PubMed ID: 18415767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endpoint measures in rheumatoid arthritis clinical trials: group summary and individual patient analysis.
    van der Heide A; Jacobs JW; Schenk Y; Bijlsma JW
    J Rheumatol; 1994 Dec; 21(12):2195-9. PubMed ID: 7699618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The methotrexate therapeutic response in rheumatoid arthritis.
    Ortendahl M; Holmes T; Schettler JD; Fries JF
    J Rheumatol; 2002 Oct; 29(10):2084-91. PubMed ID: 12375316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronicity of rheumatoid arthritis affects the responsiveness of physical function, but not of disease activity measures in rheumatoid arthritis clinical trials.
    Aletaha D; Alasti F; Smolen JS
    Ann Rheum Dis; 2015 Mar; 74(3):532-7. PubMed ID: 24431396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional impairment and disability in early rheumatoid arthritis--development over 5 years.
    Eberhardt KB; Fex E
    J Rheumatol; 1995 Jun; 22(6):1037-42. PubMed ID: 7674227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absent "Window of Opportunity" in smokers with short disease duration. Data from BARFOT, a multicenter study of early rheumatoid arthritis.
    Söderlin MK; Bergman S;
    J Rheumatol; 2011 Oct; 38(10):2160-8. PubMed ID: 21807778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register.
    Gwinnutt JM; Symmons DPM; MacGregor AJ; Chipping JR; Marshall T; Lunt M; Verstappen SMM
    Arthritis Rheumatol; 2017 Aug; 69(8):1566-1575. PubMed ID: 28425173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.